𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting

✍ Scribed by J. Dragun; S. Pérez-del-Pulgar; G. Crespo; S. Ramírez; M. Coto-Llerena; L. Mensa; J. C. García-Valdecasas; M. Navasa; X. Forns

Book ID
114805898
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
240 KB
Volume
11
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of hepatitis C virus infectio
Management of hepatitis C virus infection in the setting of liver transplantation
✍ Hector Rodriguez-Luna; Hugo E. Vargas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Posttransplantation recurrence of hepatitis C virus infection is a universal phenomenon with a highly variable natural history. 2. Approximately 10% to 25% of hepatitis C virusinfected recipients of liver allografts will develop cirrhosis within 5 years' after transplantation. 3. The 1-year actuaria

Characterization of the hepatitis C viru
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
✍ Alexander W. Tarr; Ania M. Owsianka; Judith M. Timms; C. Patrick McClure; Richar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

The mouse monoclonal antibody (MAb) AP33, recognizing a 12 amino acid linear epitope in the hepatitis C virus (HCV) E2 glycoprotein, potently neutralizes retroviral pseudoparticles (HCVpp) carrying genetically diverse HCV envelope glycoproteins. Consequently, this antibody and its epitope are highly